Company intelligence
Cordavis
Pharmaceutical Manufacturing
42 employees
Founded 2023
2 public signals
About Cordavis
Cordavis makes strategic investments to bring pharmaceutical products to the U.S. market to increase competition and lower costs. Cordavis partners with manufacturers and payors to deliver: • Sustainable cost savings for payors and patients • A reliable and predictable supply chain that minimizes disruption for patients • A responsible and viable long-term approach to deliver value and affordable products Our partnerships create a vibrant and competitive marketplace, allowing us to expand our investments in future products to shape tomorrow's health care, today. Cordavis is a wholly owned subsidiary of CVS Health.
Verified activity
Signals from Cordavis
2 published signals